Efficacy and Safety of Desmopressin (Nocturin®) 0.1 mg Tablets in Treatment of Nocturia in Participants With Benign Prostate Syndrome (BPS)
Clinical trial NCT00902265 · COMPLETED
Trial details
- NCT number
- NCT00902265
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-02-01
- Primary completion
- 2010-03-01
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.